Cartesian Therapeutics, Inc.

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Timothy C Barabe. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Timothy C Barabe har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
Director 168.357
US:RNAC / Cartesian Therapeutics, Inc. Director 24.366
US:VEEV / Veeva Systems Inc. Director 0
US:ARQL / ArQule, Inc. Director 0
US:OPXA / Opexa Therapeutics, Inc. Director 0
US:AFFX / Affymetrix, Inc. Chief Financial Officer 166.378
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Timothy C Barabe. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb RNAC / Cartesian Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i RNAC / Cartesian Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2024-08-12 RNAC BARABE TIMOTHY C 7.500 12,7000 7.500 12,7000 95.250 116 25.1400 93.300 97,95
2022-05-09 SELB BARABE TIMOTHY C 50.000 0,7744 50.000 0,7744 38.720
2021-08-18 SELB BARABE TIMOTHY C 9.000 4,0000 9.000 4,0000 36.000
2021-03-26 SELB BARABE TIMOTHY C 10.000 4,1000 10.000 4,1000 41.000
2020-10-06 SELB BARABE TIMOTHY C 50.000 1,6797 50.000 1,6797 83.985
2020-03-17 SELB BARABE TIMOTHY C 5.000 2,0000 5.000 2,0000 10.000
2019-08-13 SELB BARABE TIMOTHY C 10.000 1,7200 10.000 1,7200 17.200
2017-11-10 SELB BARABE TIMOTHY C 2.500 9,0019 2.500 9,0019 22.505
2017-11-09 SELB BARABE TIMOTHY C 2.500 9,7341 2.500 9,7341 24.335

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

RNAC / Cartesian Therapeutics, Inc. Insider Trades
Insidersalg RNAC / Cartesian Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i RNAC / Cartesian Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

RNAC / Cartesian Therapeutics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Timothy C Barabe som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-08-11 2025-08-11 4 HTFL Heartflow, Inc.
Common Stock
C - Conversion 131.578 168.357 357,75
2025-08-07 3 HTFL Heartflow, Inc.
Common Stock
36.779
2025-01-06 2025-01-02 4 RNAC Cartesian Therapeutics, Inc.
Common Stock
A - Award 2.600 24.366 11,95
2024-08-14 2024-08-12 4 RNAC Cartesian Therapeutics, Inc.
Common Stock
P - Purchase 7.500 21.766 52,57 12,70 95.250 276.428
2024-01-04 2024-01-02 4 RNAC Cartesian Therapeutics, Inc.
Common Stock
A - Award 178.000 428.013 71,20
2022-05-11 2022-05-09 4 SELB SELECTA BIOSCIENCES INC
Common Stock
P - Purchase 50.000 250.013 25,00 0,77 38.720 193.610
2022-01-18 2022-01-14 4 SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy)
M - Exercise -10.000 0 -100,00 2,10 -21.000
2022-01-18 2022-01-14 4 SELB SELECTA BIOSCIENCES INC
Common Stock
M - Exercise 10.000 200.013 5,26 2,10 21.000 420.027
2022-01-05 2022-01-03 4 SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy)
A - Award 40.000 40.000
2021-08-20 2021-08-18 4 SELB SELECTA BIOSCIENCES INC
Common Stock
P - Purchase 9.000 190.013 4,97 4,00 36.000 760.052
2021-06-23 2021-06-22 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -251 0 -100,00
2021-06-23 2021-06-22 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 251 6.643 3,93
2021-04-01 2021-03-30 4 SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy)
A - Award 40.000 40.000
2021-03-30 2021-03-26 4 SELB SELECTA BIOSCIENCES INC
Common Stock
P - Purchase 10.000 181.013 5,85 4,10 41.000 742.153
2021-03-26 2021-03-25 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -250 251 -49,90
2021-03-26 2021-03-25 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 250 6.392 4,07
2020-12-28 2020-12-25 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -251 501 -33,38
2020-12-28 2020-12-25 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 251 6.142 4,26
2020-10-15 2020-10-13 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
S - Sale -1.292 5.891 -17,99 308,69 -398.827 1.818.493
2020-10-09 2020-10-08 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
S - Sale -952 7.183 -11,70 288,00 -274.176 2.068.704
2020-10-08 2020-10-06 4 SELB SELECTA BIOSCIENCES INC
Common Stock
P - Purchase 50.000 171.013 41,32 1,68 83.985 287.251
2020-09-28 2020-09-25 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -251 752 -25,02
2020-09-28 2020-09-25 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 251 8.135 3,18
2020-06-26 2020-06-24 4 SELB SELECTA BIOSCIENCES INC
Common Warrants
M - Exercise -32.840 0 -100,00 0,12 -4.105
2020-06-26 2020-06-24 4 SELB SELECTA BIOSCIENCES INC
Common Stock
M - Exercise 32.840 121.013 37,24 1,46 47.946 176.679
2020-06-26 2020-06-25 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
A - Award 1.003 1.003
2020-06-24 2020-06-23 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
S - Sale -347 7.884 -4,22 242,00 -83.974 1.907.934
2020-06-24 2020-06-22 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
S - Sale -1.428 8.231 -14,78 238,45 -340.509 1.962.698
2020-06-23 2020-06-19 4 SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy)
A - Award 20.000 20.000
2020-06-22 2020-06-20 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -347 0 -100,00
2020-06-22 2020-06-20 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 347 9.659 3,73
2020-04-09 2020-04-08 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
S - Sale -347 9.312 -3,59 156,00 -54.132 1.452.672
2020-03-23 2020-03-20 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -346 347 -49,93
2020-03-23 2020-03-20 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 346 9.659 3,72
2020-03-19 2020-03-17 4 SELB SELECTA BIOSCIENCES INC
Common Stock
P - Purchase 5.000 88.173 6,01 2,00 10.000 176.346
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -20.000 0 -100,00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -20.000 0 -100,00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -20.000 0 -100,00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -15.000 0 -100,00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -15.000 0 -100,00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -15.000 0 -100,00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -15.000 0 -100,00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -15.000 0 -100,00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -15.000 0 -100,00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Stock Option (Right to Buy)
D - Sale to Issuer -40.000 0 -100,00
2020-01-16 2020-01-16 4 ARQL ARQULE INC
Common Stock
U - Other -146.897 0 -100,00 20,00 -2.937.940
2019-12-26 2019-12-23 4 SELB SELECTA BIOSCIENCES INC
Warrants
A - Award 32.840 32.840 0,12 4.105 4.105
2019-12-26 2019-12-23 4 SELB SELECTA BIOSCIENCES INC
Common Stock
A - Award 65.681 83.173 375,49 1,46 95.894 121.433
2019-12-20 2019-12-20 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -347 693 -33,37
2019-12-20 2019-12-20 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 347 9.313 3,87
2019-09-23 2019-09-20 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -347 1.040 -25,02
2019-09-23 2019-09-20 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 347 8.966 4,03
2019-08-15 2019-08-13 4 SELB SELECTA BIOSCIENCES INC
Common Stock
P - Purchase 10.000 17.492 133,48 1,72 17.200 30.086
2019-06-21 2019-06-20 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
A - Award 1.387 1.387
2019-06-19 2019-06-18 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
S - Sale -727 8.619 -7,78 167,19 -121.549 1.441.037
2019-06-18 2019-06-14 4 SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy)
A - Award 10.000 10.000
2019-06-17 2019-06-13 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -727 0 -100,00
2019-06-17 2019-06-13 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 727 9.346 8,43
2019-05-15 2019-05-14 4 ARQL ARQULE INC
Director Stock Options
A - Award 40.000 40.000
2019-04-08 2019-04-04 4 ARQL ARQULE INC
Director Stock Option (Right to Buy)
M - Exercise -10.000 0 -100,00
2019-04-08 2019-04-04 4 ARQL ARQULE INC
Common Stock
M - Exercise 10.000 146.897 7,30 3,87 38.700 568.491
2019-04-03 2019-04-02 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
S - Sale -727 8.619 -7,78 127,40 -92.623 1.098.104
2019-03-15 2019-03-13 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -727 727 -50,00
2019-03-15 2019-03-13 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 727 9.346 8,43
2018-12-14 2018-12-13 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -727 1.454 -33,33
2018-12-14 2018-12-13 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 727 8.619 9,21
2018-09-28 2018-09-27 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
S - Sale -727 7.892 -8,43 105,00 -76.335 828.660
2018-09-14 2018-09-13 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -727 2.181 -25,00
2018-09-14 2018-09-13 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 727 8.619 9,21
2018-06-22 2018-06-21 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -701 0 -100,00
2018-06-22 2018-06-21 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 701 7.892 9,75
2018-06-19 2018-06-15 4 SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy)
A - Award 10.000 10.000
2018-06-15 2018-06-13 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
A - Award 2.908 2.908
2018-06-04 2018-05-31 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
S - Sale 701 7.191 10,80 77,54 54.356 557.590
2018-05-10 2018-05-08 4 ARQL ARQULE INC
Director Stock Options
A - Award 20.000 20.000
2018-03-23 2018-03-21 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -701 701 -50,00
2018-03-23 2018-03-21 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 701 7.892 9,75
2018-03-09 2018-03-08 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
S - Sale 1.993 7.191 38,34 78,16 155.773 562.049
2017-12-22 2017-12-21 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -701 1.402 -33,33
2017-12-22 2017-12-21 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 701 9.184 8,26
2017-11-13 2017-11-10 4 SELB SELECTA BIOSCIENCES INC
Common Stock
P - Purchase 2.500 7.492 50,08 9,00 22.505 67.442
2017-11-13 2017-11-09 4 SELB SELECTA BIOSCIENCES INC
Common Stock
P - Purchase 2.500 4.992 100,32 9,73 24.335 48.593
2017-09-25 2017-09-21 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -701 2.103 -25,00
2017-09-25 2017-09-21 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 701 8.483 9,01
2017-06-23 2017-06-22 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -1.292 0 -100,00
2017-06-23 2017-06-22 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 1.292 7.782 19,91
2017-06-23 2017-06-21 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
A - Award 2.804 2.804
2017-06-20 2017-06-16 4 SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy)
A - Award 6.410 6.410
2017-05-24 2017-05-23 4 ARQL ARQULE INC
Director Stock Options
A - Award 20.000 20.000
2017-04-04 2017-03-27 4 SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy)
M - Exercise -2.492 10.328 -19,44
2017-04-04 2017-03-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock
M - Exercise 2.492 2.492 11,00 27.412 27.412
2017-04-04 2016-07-29 4/A SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy)
A - Award 12.820 12.820
2017-04-03 2017-03-30 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
S - Sale -1.292 6.490 -16,60 51,04 -65.944 331.250
2017-03-24 2017-03-22 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -1.292 1.292 -50,00
2017-03-24 2017-03-22 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 1.292 7.782 19,91
2017-02-21 2017-02-18 4 ARQL ARQULE INC
Common Stock
A - Award 5.000 136.897 3,79 1,20 6.000 164.276
2017-01-18 2017-01-17 4 ARQL ARQULE INC
Common Stock
A - Award 784 131.897 0,60 1,53 1.200 201.802
2017-01-04 2016-12-30 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
S - Sale -1.292 6.490 -16,60 40,54 -52.380 263.114
2016-12-27 2016-12-22 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -1.292 2.584 -33,33
2016-12-27 2016-12-22 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 1.292 7.782 19,91
2016-11-22 2016-11-18 4 OPXA Opexa Therapeutics, Inc.
Warrants (Right to Buy)
S - Sale -16.000 0 -100,00 0,01 -94
2016-11-22 2016-11-18 4 OPXA Opexa Therapeutics, Inc.
Common Stock
S - Sale -7.809 12.910 -37,69 0,55 -4.302 7.112
2016-11-22 2016-11-18 4 OPXA Opexa Therapeutics, Inc.
Common Stock
S - Sale -7.105 20.719 -25,54 0,55 -3.908 11.395
2016-11-21 2016-11-18 4 ARQL ARQULE INC
Common Stock
A - Award 4.285 131.113 3,38 1,40 5.999 183.558
2016-11-16 2016-11-15 4 ARQL ARQULE INC
Common Stock
A - Award 1.413 126.828 1,13 1,38 1.950 175.023
2016-10-26 2016-10-25 4 ARQL ARQULE INC
Common Stock
A - Award 531 125.415 0,43 1,41 749 176.835
2016-10-04 2016-09-30 4 OPXA Opexa Therapeutics, Inc.
Common Stock
A - Award 6.455 27.824 30,21
2016-09-26 2016-09-22 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -1.292 3.876 -25,00
2016-09-26 2016-09-22 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 1.292 6.490 24,86
2016-09-22 2016-09-20 4 ARQL ARQULE INC
Common Stock
A - Award 1.500 124.884 1,22 1,60 2.400 199.814
2016-08-22 2016-08-18 4 ARQL ARQULE INC
Common Stock
A - Award 3.921 123.384 3,28 1,53 5.999 188.778
2016-08-02 2016-07-29 4 SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy)
A - Award 12.820 12.820
2016-07-28 2016-07-27 4 ARQL ARQULE INC
Common Stock
A - Award 460 119.463 0,39 1,63 750 194.725
2016-07-19 2016-07-18 4 ARQL ARQULE INC
Common Stock
A - Award 736 119.003 0,62 1,63 1.200 193.975
2016-07-01 2016-06-30 4 OPXA Opexa Therapeutics, Inc.
Common Stock
A - Award 6.455 21.369 43,28
2016-06-24 2016-06-22 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
A - Award 5.168 5.168
2016-06-10 2016-06-09 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -1.733 0 -100,00
2016-06-10 2016-06-09 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 1.733 5.198 50,01
2016-05-25 2016-05-24 4 ARQL ARQULE INC
Director Stock Options
A - Award 20.000 20.000
2016-05-25 2016-05-24 4 ARQL ARQULE INC
Common Stock
A - Award 714 118.267 0,61 1,68 1.200 198.689
2016-05-19 2016-05-18 4 ARQL ARQULE INC
Common Stock
A - Award 3.773 117.553 3,32 1,59 5.999 186.909
2016-05-18 2016-05-16 4 OPXA Opexa Therapeutics, Inc.
Common Stock
A - Award 6.455 14.914 76,31
2016-04-27 2016-04-26 4 ARQL ARQULE INC
Common Stock
A - Award 449 113.780 0,40 1,67 750 190.013
2016-03-23 2016-03-22 4 ARQL ARQULE INC
Common Stock
A - Award 693 112.928 0,62 1,73 1.199 195.365
2016-03-11 2016-03-09 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -1.732 1.733 -49,99
2016-03-11 2016-03-09 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 1.732 3.465 99,94
2016-02-25 2016-02-24 4 ARQL ARQULE INC
Common Stock
A - Award 403 112.638 0,36 1,86 750 209.507
2016-02-22 2016-02-18 4 ARQL ARQULE INC
Common Stock
A - Award 3.243 112.235 2,98 1,85 6.000 207.635
2016-01-20 2016-01-19 4 ARQL ARQULE INC
Common Stock
A - Award 670 108.992 0,62 1,79 1.199 195.096
2016-01-04 2015-12-31 4 OPXA Opexa Therapeutics, Inc.
Common Stock
A - Award 1.354 8.460 19,05
2015-12-11 2015-12-09 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
M - Exercise -1.733 3.465 -33,34
2015-12-11 2015-12-09 4 VEEV VEEVA SYSTEMS INC
Class A Common Stock
M - Exercise 1.733 1.733
2015-11-19 2015-11-18 4 ARQL ARQULE INC
Common Stock
A - Award 2.459 108.322 2,32 2,44 6.000 264.306
2015-11-18 2015-11-17 4 ARQL ARQULE INC
Common Stock
A - Award 801 105.863 0,76 2,43 1.946 257.247
2015-10-29 2015-10-28 4 ARQL ARQULE INC
Common Stock
A - Award 324 105.062 0,31 2,31 748 242.693
2015-10-02 2015-09-30 4 OPXA Opexa Therapeutics, Inc.
Common Stock
A - Award 1.200 7.106 20,32
2015-09-23 2015-09-22 4 ARQL ARQULE INC
Common Stock
A - Award 1.170 104.738 1,13 2,05 2.398 214.713
2015-09-11 2015-09-09 4 VEEV VEEVA SYSTEMS INC
Restricted Stock Units
A - Award 5.198 5.198
2015-09-11 3 VEEV VEEVA SYSTEMS INC
No securities are beneficially owned
0
2015-08-19 2015-08-18 4 ARQL ARQULE INC
Common Stock
A - Award 3.529 103.568 3,53 1,70 5.999 176.066
2015-07-30 2015-07-29 4 ARQL ARQULE INC
Common Stock
A - Award 441 100.039 0,44 1,70 750 170.066
2015-07-29 2015-07-27 4 ARQL ARQULE INC
Common Stock
A - Award 681 99.598 0,69 1,76 1.199 175.292
2015-07-01 2015-06-30 4 OPXA Opexa Therapeutics, Inc.
Common Stock
A - Award 8.427 47.245 21,71
2015-06-01 2015-05-28 4 ARQL ARQULE INC
Common Stock
A - Award 666 98.917 0,68 1,80 1.199 178.051
2015-05-19 2015-05-18 4 ARQL ARQULE INC
Common Stock
A - Award 3.243 98.251 3,41 1,85 6.000 181.764
2015-05-12 2015-05-11 4 ARQL ARQULE INC
Director Stock Options
A - Award 15.000 15.000
2015-05-12 2015-05-11 4 ARQL ARQULE INC
Common Stock
A - Award 666 95.008 0,71 1,80 1.199 171.014
2015-05-01 2015-04-30 4 ARQL ARQULE INC
Common Stock
A - Award 365 94.342 0,39 2,05 748 193.401
2015-04-09 2015-04-08 4 OPXA Opexa Therapeutics, Inc.
Warrants (Right to Buy)
M - Exercise 16.000 16.000
2015-04-09 2015-04-08 4 OPXA Opexa Therapeutics, Inc.
Subscription Rights (Right to Buy)
M - Exercise -16.000 0 -100,00
2015-04-09 2015-04-08 4 OPXA Opexa Therapeutics, Inc.
Common Stock
M - Exercise 16.000 38.818 70,12
2015-04-01 2015-03-31 4 OPXA Opexa Therapeutics, Inc.
Common Stock
A - Award 6.818 22.818 42,61
2015-04-01 2015-03-30 4 OPXA Opexa Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 23.804 23.804
2015-04-01 2015-03-30 4 OPXA Opexa Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 71.410 71.410
2015-03-19 2015-03-17 4 ARQL ARQULE INC
Common Stock
A - Award 528 93.977 0,57 2,27 1.199 213.328
2015-02-26 2015-02-25 4 ARQL ARQULE INC
Common Stock
A - Award 454 93.449 0,49 1,65 749 154.191
2015-02-20 2015-02-18 4 ARQL ARQULE INC
Common Stock
A - Award 4.347 92.995 4,90 1,38 5.999 128.333
2015-01-21 2015-01-20 4 ARQL ARQULE INC
Common Stock
A - Award 1.034 88.648 1,18 1,16 1.199 102.832
2014-11-19 2014-11-18 4 ARQL ARQULE INC
Common Stock
A - Award 6.209 87.614 7,63 1,28 7.948 112.146
2014-09-25 2014-09-23 4 ARQL ARQULE INC
Common Stock
A - Award 2.105 81.405 2,65 1,14 2.400 92.802
2014-09-18 2014-09-17 4 OPXA Opexa Therapeutics, Inc.
Common Stock
P - Purchase 10.000 16.000 166,67 1,15 11.500 18.400
2014-08-20 2014-08-18 4 ARQL ARQULE INC
Common Stock
A - Award 4.477 79.300 5,98 1,34 5.999 106.262
2014-07-31 2014-07-30 4 ARQL ARQULE INC
Common Stock
A - Award 547 74.823 0,74 1,37 749 102.508
2014-07-21 2014-07-17 4 ARQL ARQULE INC
Common Stock
A - Award 863 74.276 1,18 1,39 1.200 103.244
2014-05-19 2014-05-16 4 ARQL ARQULE INC
Common Stock
A - Award 4.109 73.413 5,93 1,46 5.999 107.183
2014-05-15 2014-05-13 4 ARQL ARQULE INC
Director Stock Options
A - Award 15.000 15.000
2014-05-15 2014-05-13 4 ARQL ARQULE INC
Common Stock
A - Award 845 69.304 1,23 1,42 1.200 98.412
2014-05-01 2014-04-30 4 ARQL ARQULE INC
Common Stock
A - Award 462 68.459 0,68 1,62 748 110.904
2014-03-21 2014-03-19 4 OPXA Opexa Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 4.300 4.300
2014-03-21 2014-03-19 4 OPXA Opexa Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 12.900 12.900
2014-03-21 2014-03-19 4 OPXA Opexa Therapeutics, Inc.
Common Stock
A - Award 6.000 6.000
2014-03-21 3 OPXA Opexa Therapeutics, Inc.
Common Stock
0
2014-03-19 2014-03-18 4 ARQL ARQULE INC
Common Stock
A - Award 560 67.997 0,83 2,14 1.198 145.514
2014-03-05 2014-02-26 4 ARQL ARQULE INC
Common Stock
A - Award 326 67.437 0,49 2,30 750 155.105
2014-02-19 2014-02-18 4 ARQL ARQULE INC
Common Stock
A - Award 2.654 67.111 4,12 2,26 5.998 151.671
2014-01-24 2014-01-22 4 ARQL ARQULE INC
Common Stock
A - Award 466 64.457 0,73 2,57 1.198 165.654
2013-11-25 2013-11-21 4 ARQL ARQULE INC
Common Stock
A - Award 881 63.991 1,40 2,21 1.947 141.420
2013-11-19 2013-11-18 4 ARQL ARQULE INC
Common Stock
A - Award 2.690 63.110 4,45 2,23 5.999 140.735
2013-11-01 2013-10-30 4 ARQL ARQULE INC
Common Stock
A - Award 324 60.420 0,54 2,31 748 139.570
2013-09-23 2013-09-20 4 ARQL ARQULE INC
Common Stock
A - Award 1.057 60.096 1,79 2,27 2.399 136.418
2013-09-10 2013-07-24 4 ARQL ARQULE INC
Common Stock
A - Award 304 59.039 0,52 2,46 748 145.236
2013-08-20 2013-08-16 4 ARQL ARQULE INC
Common Stock
A - Award 2.419 58.735 4,30 2,48 5.999 145.663
2013-07-22 2013-07-18 4 ARQL ARQULE INC
Common Stock
A - Award 458 56.316 0,82 2,62 1.200 147.548
2013-05-21 2013-05-20 4 ARQL ARQULE INC
Director Stock Options
A - Award 15.000 15.000
2013-05-21 2013-05-20 4 ARQL ARQULE INC
Common Stock
A - Award 431 55.858 0,78 2,78 1.198 155.285
2013-05-21 2013-05-17 4 ARQL ARQULE INC
Common Stock
A - Award 2.142 55.427 4,02 2,80 5.998 155.196
2013-04-25 2013-04-24 4 ARQL ARQULE INC
Common Stock
A - Award 250 53.285 0,47 3,00 750 159.855
2013-03-20 2013-03-18 4 AFFX AFFYMETRIX INC
Common Stock
F - Taxes -2.182 166.378 -1,29 4,68 -10.212 778.649
2013-03-20 2013-03-18 4 ARQL ARQULE INC
Common Stock
A - Award 465 53.035 0,88 2,58 1.200 136.830
2013-03-04 2013-02-28 4 ARQL ARQULE INC
Common Stock
A - Award 304 52.570 0,58 2,46 748 129.322
2013-02-19 2013-02-17 4 AFFX AFFYMETRIX INC
Common Stock
F - Taxes -1.097 168.560 -0,65 3,85 -4.223 648.956
2013-02-19 2013-02-18 4 ARQL ARQULE INC
Common Stock
A - Award 2.419 52.266 4,85 2,48 5.999 129.620
2013-01-15 2013-01-14 4 ARQL ARQULE INC
Common Stock
A - Award 478 49.847 0,97 2,51 1.200 125.116
2012-11-20 2012-11-16 4 ARQL ARQULE INC
Common Stock
A - Award 3.367 49.369 7,32 2,36 7.946 116.511
2012-11-19 2012-11-17 4 AFFX AFFYMETRIX INC
Common Stock
F - Taxes -4.127 168.157 -2,40 3,01 -12.422 506.153
2012-10-30 2012-10-29 4 ARQL ARQULE INC
Common Stock
A - Award 298 46.002 0,65 2,51 748 115.465
2012-09-25 2012-09-21 4 ARQL ARQULE INC
Common Stock
A - Award 458 45.704 1,01 5,24 2.400 239.489
2012-09-04 2012-08-30 4 arql ARQULE INC
Common Stock
A - Award 224 45.246 0,50 5,34 1.196 241.614
2012-08-21 2012-08-21 4 AFFX AFFYMETRIX INC
Common Stock
P - Purchase 10.000 172.284 6,16 3,75 37.500 646.065
2012-08-21 2012-08-19 4 AFFX AFFYMETRIX INC
Common Stock
F - Taxes -1.376 162.284 -0,84 3,86 -5.311 626.416
2012-08-21 2012-08-17 4 ARQL ARQULE INC
Common Stock
A - Award 882 45.022 2,00 6,80 5.998 306.150
2012-08-17 2012-08-17 4 AFFX AFFYMETRIX INC
Common Stock
P - Purchase 5.550 163.660 3,51 3,99 22.144 653.003
2012-08-14 2012-08-13 4 AFFX AFFYMETRIX INC
Common Stock
P - Purchase 4.450 158.110 2,90 3,99 17.756 630.859
2012-07-26 2012-07-25 4 ARQL ARQULE INC
Common Stock
A - Award 127 44.140 0,29 5,90 749 260.426
2012-07-16 2012-07-12 4 ARQL ARQULE INC
Common Stock
A - Award 193 44.013 0,44 6,21 1.199 273.321
2012-05-29 2012-05-24 4 ARQL ARQULE INC
Director Stock Options
A - Award 15.000 15.000
2012-05-29 2012-05-24 4 ARQL ARQULE INC
Common Stock
A - Award 206 43.820 0,47 5,82 1.199 255.032
2012-05-21 2012-05-18 4 ARQL ARQULE INC
Common Stock
A - Award 908 43.614 2,13 5,78 5.248 252.089
2012-05-15 2012-05-14 4 ARQL ARQULE INC
Common Stock
A - Award 185 42.706 0,44 6,47 1.197 276.308
2012-04-30 2012-04-27 4 ARQL ARQULE INC
Common Stock
A - Award 82 42.521 0,19 7,27 596 309.128
2012-03-23 2012-03-22 4 ARQL ARQULE INC
Common Stock
A - Award 166 42.439 0,39 7,21 1.197 305.985
2012-03-20 2012-03-18 4 AFFX AFFYMETRIX INC
Common Stock
F - Taxes -2.066 153.660 -1,33 4,44 -9.173 682.250
2012-02-27 2012-02-23 4 ARQL ARQULE INC
Common Stock
A - Award 80 42.273 0,19 7,50 600 317.048
2012-02-22 2012-02-17 4 AFFX AFFYMETRIX INC
Common Stock
F - Taxes -1.048 155.726 -0,67 4,61 -4.831 717.897
2012-02-21 2012-02-18 4 ARQL ARQULE INC
Common Stock
A - Award 670 42.193 1,61 7,83 5.246 330.371
2012-02-03 2012-02-01 4 ARQL ARQULE INC
Common Stock
A - Award 150 41.523 0,36 7,95 1.192 330.108
2012-01-17 2012-01-14 4 ARQL ARQULE INC
Common Stock
A - Award 201 41.373 0,49 5,96 1.198 246.583
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)